Cardiac Implantable Electronic Device Infections: Presentation, Management, and Patient Outcomes
Tarakji KG, Chan EJ, Cantillo DJ, et al.
Heart Rhythm 2010;7:1043-1047.
Study Question: What are the outcomes of patients with an infected pacemaker or implantable cardioverter-defibrillator?
Long-Term Outcomes of Surgical Aortic Fenestration for Complicated Acute Type B Aortic Dissections
Trimarchi S, Jonker FH, Muhs BE, et al.
J Vasc Surg 2010;52:261-266.
Study Question: What are the long-term results of suprarenal and infrarenal surgical fenestration for acute type B aortic dissections?
Gene Dosage of the Common Variant 9p21 Predicts Severity of Coronary Artery Disease
Dandona S, Stewart AF, Chen L, et al.
J Am Coll Cardiol 2010;56:479-486.
Study Question: What is the effect of 9p21 gene dosage on severity of coronary artery disease (CAD)?
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Bhatt DL, Eagle KA, Ohman EM, et al., on behalf of the REACH Registry Investigators.
JAMA 2010;Aug 30:[Epub ahead of print].
Study Question: Can the relative risk of cardiovascular events in stable outpatients with various initial manifestations of atherothrombosis be performed using simple clinical descriptors?
Exercise Capacity and Mortality in Older Men: A 20-Year Follow-Up Study
Kokkinos P, Myers J, Faselis C, et al.
Circulation 2010;122:790-797.
Study Question: What is the association between exercise capacity and all-cause mortality in elderly men?
The New High-Sensitivity Cardiac Troponin T Assay Improves Risk Assessment in Acute Coronary Syndromes
Lindahl B, Venge P, James S.
Am Heart J 2010;160:224-229.
Study Question: How does the new high-sensitivity cardiac troponin T (hs-cTnT) assay compare with the third-generation cTnT assay for risk assessment in acute coronary syndromes (ACS)?
Viral Endomyocardial Infection Is an Independent Predictor and Potentially Treatable Risk Factor for Graft Loss and Coronary Vasculopathy in Pediatric Cardiac Transplant Recipients
Moulik M, Breinholt JP, Dreyer WJ, et al.
J Am Coll Cardiol 2010;56:582-592.
Study Question: What is the prevalence and outcome of viral endomyocardial infection after pediatric cardiac transplantation?
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial
The FUTURA/OASIS-8 Trial Group.
JAMA 2010;Aug 31:[Epub ahead of print].
Study Question: What is the safety of two unfractionated heparin (UFH) regimens during percutaneous coronary intervention (PCI) in high-risk patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS) initially treated with fondaparinux?
Randomized Comparison of Eptifibatide Versus Abciximab in Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction: Results of the EVA-AMI Trial
Zeymer U, Margenet A, Haude M, et al.
J Am Coll Cardiol 2010;56:463-469.
Study Question: What is the efficacy of eptifibatide compared to abciximab in patients undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI)?
Elective Intra-Aortic Balloon Counterpulsation During High-Risk Percutaneous Coronary Intervention: A Randomized Controlled Trial
Perera D, Stables R, Thomas M, et al., on behalf of the BCIS-1 Investigators.
JAMA 2010;304:867-874.
Study Question: What is the benefit of routine intra-aortic balloon pump (IABP) in patients with severe left ventricular dysfunction undergoing percutaneous coronary intervention (PCI) for extensive coronary artery disease?
|